Systemic Inflammatory Diseases (SIDs), what's in a name

Acta Clinica Belgica

Volumn 62, Issue 1, 2007, Pages 21-25

  Knockaert, Daniël C ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Collagen vascular diseases; Connective tissue diseases; Multi system diseases; Systemic diseases; Systemic inflammatory diseases; Vasculitis

Indexed keywords

ERGOTAMINE; METHYSERGIDE; PERGOLIDE;

AORTA VALVE REGURGITATION; AUTOPSY; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; HEART MUSCLE FIBROSIS; HUMAN; INCIDENCE; PATIENT SELECTION; PERICARDIAL DISEASE; PLEURAL FIBROSIS; RETROPERITONEAL FIBROSIS; REVIEW; STORAGE DISEASE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VALVULAR HEART DISEASE;

EID: 34047173594     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2007.004     Document Type: Review

References (24)

1. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-43.
2. de Kleijn EMHA, Vandenbroucke JP, van der Meer JWM, and the Netherlands FUO study group. Fever of unknown origin (FUO) I. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. Medicine 1997; 76: 392-400.
3. Luqmani RA, Pathare S, Kwok-Fai TL. How to diagnose and treat secondary forms of vasculitis. Best Pract Res Clin Rheumatol 2005; 19: 321-36.
4. Friedman DR, Wolfsthal SD. Cocaine-induced pseudovasculitis. Mayo Clin Proc 2005; 80: 671-3.
5. Van Camp G, Flamez A, Cosyns B, et al. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease. Lancet 2004; 363: 1179-83.
6. Waller EA, Kaplan J, Heckman MG. Valvular heart disease in patients taking pergolide. Mayo Clin Proc 2005; 80: 1016-20.
7. Pritchett AM, Morrison JF, Edwards WD, et al. Valvular heart disease in patients taking pergolide. Mayo Clin Proc 2002; 77: 1280-6.
8. Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005; 352: 362-72.
9. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med 2003; 348: 2656-68.
10. Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an underrecognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003; 138: 338-46.
11. Schiffmann R, Ries M. Fabry's disease - an important risk factor for stroke. Lancet 2005; 366: 1754-6.
12. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Cuur Opin Rheumatol 2005; 17: 586-99.
13. Haroche J, Amoura Z, Dion E, et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease. Medicine 2004; 83: 371-92.
14. Watts RA, Lane S, Scott DG. What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 2005; 19: 191-207.
15. Saleh A, Stone JH. Classification and diagnostic criteria in systemic vasculitis. Best Pract Res Clin Rheumatol 2005; 19: 209-21.
16. Lane SE, Watts RA, Shepstone L, Scott DGI. Primary systemic vasculitis: clinical features and mortality. Q J Med 2005; 98: 97-111.
17. Somer T, Finegold SM. Vasculitides associated with infections, immunization and antimicrobial drugs. Clin Infect Dis 1995; 20: 1010-36.
18. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
19. Oliveira GH, Seward JB, Tsang TS, Specks U. Echocardiographic findings in patients with Wegener granulomatosis. Mayo Clin Proc 2005; 80: 1435-40.
20. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45: 1683-90.
21. Gonzalez-Gay MA, García-Porrúa C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine 1999; 78: 292-308.
22. Yoshida Y, Morimoto S, Hiramitsu S, et al. Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 1997; 134: 382-6.
23. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995; 122: 502-7.
24. Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med 1998; 129: 114-22.